Inspectors cite the consolidator trading as Meridian Freight Partners over sterility assurance
The observation that closes a facility is rarely the dramatic one.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 2 of 5 of this archive, newest first.
The observation that closes a facility is rarely the dramatic one.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
A great deal of practice has grown up around intermittent schedules. The randomised evidence for any of them is, as far as the Journal can establish, nil.
What the Journal asks when a document arrives unsigned, and what the answers have been.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The molecular engineering that turned a peptide with a two-minute half-life into a once-weekly drug.
Two withdrawal-design trials tell us what happens when treatment stops. Neither tells us what the lowest effective maintenance dose is.
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What would be needed to catch each of these, and what it would cost.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Efficacy was never the question in this appraisal. Duration of treatment was.
A badge asserts that something was tested. It does not assert what, when, on whose sample, by what method, or whether the lot on sale is the lot that was tested.
A rotation scheme that is too complicated will not be followed. We describe the simple ones that are.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Chromatographic purity is cheap, fast and comparable-looking. Those three properties, and not its usefulness, explain why it became the industry’s single figure of merit.
A flag is a probability statement about a population. It is not a statement about the person holding the printout.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
Follow the resin, not the catalogue.
A plausible mechanism, a measurable change, and no outcome data. This is what an open question looks like.
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.
Reported from the analysis, not from a warning notice.
Efficacy was never the question in this appraisal. Duration of treatment was.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
A short audit procedure, usable by anyone holding a certificate and a calculator.
The practice is near-universal, clinically sensible, and supported by observational data rather than randomised comparison. We say which is which.